ConductScience.org, home

Paper23756608

Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.

Lasser RA and 7 others. Neuropsychopharmacology, 2013. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. Papers, record 23756608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23756608

Download JSON
Disease
schizophrenia345 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.
PubMed
Journal
Neuropsychopharmacology
PubMed
Year
2013
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lasser RARobert A
2Dirks BBryan
3Nasrallah HHenry
4Kirsch CCourtney
5Gao JJoseph
6Pucci MLMichael L
7Knesevich MAMary A
8Lindenmayer JPJean-Pierre

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DextroamphetamineMajor topic
Dopamine AgonistsMajor topic
SchizophreniaMajor topic
Adult
Antipsychotic Agents
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Lisdexamfetamine Dimesylate
Male
Outpatients

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00922272Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsResults

Source ClinicalTrials.gov

Download CSV of trials

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12884687Provocative tests with psychostimulant drugs in schizophrenia.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2884687PubMed
22278986A depression rating scale for schizophrenics.Schizophr Res1990https://conductscience.org/library/papers/2278986PubMed
317349856Neurobiology of dopamine in schizophrenia.Int Rev Neurobiol2007https://conductscience.org/library/papers/17349856PubMed
417244172Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?Acta Psychiatr Scand2007https://conductscience.org/library/papers/17244172PubMed
517629443Psychometric evaluation of the Amphetamine Cessation Symptom Assessment.J Subst Abuse Treat2008https://conductscience.org/library/papers/17629443PubMed
617201860Negative symptoms of schizophrenia: a problem that will not go away.Acta Psychiatr Scand2007https://conductscience.org/library/papers/17201860PubMed
712832232Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.Am J Psychiatry2003https://conductscience.org/library/papers/12832232PubMed
82062986Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/2062986PubMed
93616518The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophr Bull1987https://conductscience.org/library/papers/3616518PubMed
1016198197Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.Clin Ther2005https://conductscience.org/library/papers/16198197PubMed
1110394474Increased dopamine transmission in schizophrenia: relationship to illness phases.Biol Psychiatry1999https://conductscience.org/library/papers/10394474PubMed
122574607A rating scale for drug-induced akathisia.Br J Psychiatry1989https://conductscience.org/library/papers/2574607PubMed
1318644851Negative symptoms in schizophrenia: avolition and Occam's razor.Schizophr Bull2010https://conductscience.org/library/papers/18644851PubMed
149448657The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.J Clin Psychiatry1997https://conductscience.org/library/papers/9448657PubMed
152861718Differential response to amphetamine in schizophrenia.Acta Psychiatr Scand1985https://conductscience.org/library/papers/2861718PubMed
1615339823Stimulant psychosis: systematic review.Br J Psychiatry2004https://conductscience.org/library/papers/15339823PubMed
176711703Treatment of negative schizophrenia with d-amphetamine.Am J Psychiatry1984https://conductscience.org/library/papers/6711703PubMed
1815741466Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.Am J Psychiatry2005https://conductscience.org/library/papers/15741466PubMed
1919012818Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.J Clin Psychiatry2008https://conductscience.org/library/papers/19012818PubMed
206817367Partial improvement in negative schizophrenic symptoms after amphetamine.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6817367PubMed

See all 29 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
40595332Long term safety of ADHD medication in patients with schizophrenia spectrum disorders.Mol Psychiatry2025https://conductscience.org/library/papers/40595332PubMed
40227151Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study.Schizophr Bull2025https://conductscience.org/library/papers/40227151PubMed
39337126Pharmacological Treatments of Negative Symptoms in Schizophrenia-An Update.J Clin Med2024https://conductscience.org/library/papers/39337126PubMed
39205914Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.Contemp Clin Trials Commun2024https://conductscience.org/library/papers/39205914PubMed
38842809Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis.JAMA Netw Open2024https://conductscience.org/library/papers/38842809PubMed
37358825Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.Schizophr Bull2023https://conductscience.org/library/papers/37358825PubMed
35884767BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling "Negative-Like" Symptoms of Schizophrenia.Biomedicines2022https://conductscience.org/library/papers/35884767PubMed
34227057Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.Neurosci Bull2021https://conductscience.org/library/papers/34227057PubMed
33603883Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review).Exp Ther Med2021https://conductscience.org/library/papers/33603883PubMed
32318751Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment.Psychopharmacology (Berl)2020https://conductscience.org/library/papers/32318751PubMed
31445502Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients.Neuropsychopharmacology2019https://conductscience.org/library/papers/31445502PubMed
29687627Anhedonia in depression and schizophrenia: A transdiagnostic challenge.CNS Neurosci Ther2018https://conductscience.org/library/papers/29687627PubMed
29627173Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge.Schizophr Res2018https://conductscience.org/library/papers/29627173PubMed
28243210The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.Front Psychiatry2017https://conductscience.org/library/papers/28243210PubMed
27798224Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients.Schizophr Bull2017https://conductscience.org/library/papers/27798224PubMed
27376016Treating Negative Symptoms in Schizophrenia: an Update.Curr Treat Options Psychiatry2016https://conductscience.org/library/papers/27376016PubMed
27372312Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.CNS Drugs2016https://conductscience.org/library/papers/27372312PubMed
27143885Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamine.Neuropsychiatr Dis Treat2016https://conductscience.org/library/papers/27143885PubMed
26694811Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Psychopharmacology (Berl)2016https://conductscience.org/library/papers/26694811PubMed
25312027Wake-promoting pharmacotherapy for psychiatric disorders.Curr Psychiatry Rep2014https://conductscience.org/library/papers/25312027PubMed

See all 22 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
LISDEXAMFETAMINE DIMESYLATECHEMBL1201178Results1https://conductscience.org/library/drugs/CHEMBL1201178

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23756608

GET https://conductscience.org/api/papers/v1/23756608/references?page=2